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Abstract
Purpose: To determine the diagnostic value of breast magnetic resonance imaging (MRI) in detecting axillary meta-
static node in newly diagnosed breast cancer, we assessed the sensitivity, specificity, positive predictive value (PPV), 
and negative predictive value (NPV) of breast MRI.
Material and methods: Data were collected retrospectively from January 2011 to December 2018. Preoperative breast 
MRI of women with newly diagnosed breast cancer were reviewed to evaluate the axillary nodal staging by using the 
morphological characteristic of metastatic axillary lymph node. Statistical analysis was performed to assess the per-
formance of breast MRI in diagnosing metastatic axillary lymph nodes based on the pathological result.
Results: A total of 131 women with breast cancer were analysed. Two hundred and twenty-seven axillary lymph 
nodes from preoperative breast MRIs were considered to be metastasis. 65.65% (86 patients) of the breast MRI re-
sults matched with the pathological results: 37 patients with N0 stage, 39 patients with N1 stage, eight patients with  
N2 stage, and two patients with N3 stage. Sensitivity of breast MRI for axillary nodal staging was 98.5% (95% CI: 
92-100%), and the negative predictive value was 96.4% (86.2-99.9%). Specificity of breast MRI for axillary nodal 
staging was 57.8% (44.8-70.1%) and the positive predictive value was 71% (60.6-79.9%).
Conclusions: Our study showed that the breast MRI had a high sensitivity (98.5%) and high NPV (96.4%) in detecting 
metastatic axillary lymph nodes, but its specificity was only fair (57.8%). Overestimation and underestimation of the 
MRI in N staging were also found in 20.61% and 12.98% of cases, respectively.
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Introduction
The axillary nodal status is one of the most important prog-
nostic factors in patients with invasive breast cancer be-
cause it can help doctors choose the most appropriate treat-
ment (i.e. systemic chemotherapy and/or radiation therapy) 
for their patients. Sentinel lymph node biopsy (SLNB) is 
the primary method used to exclude axillary metastases in 
most cases with early stage breast cancer. A positive SLNB 
result indicates that the patient will usually undergo axillary 
lymph node dissection (ALND) with removal of level I and 
II axillary nodes [1]. The National Comprehensive Cancer 
Network (NCCN) guideline recommends radiation therapy 
to the whole breast or chest wall and regional lymph nodes 
in woman with positive lymph nodes [2]. Thus, prediction 
of nodal metastasis in preoperative breast cancer is influen-
tial in the treatment plan.
Breast magnetic resonance imaging (MRI) can be uti-
lised to evaluate the extension of the breast cancer and 
affected area such as the skin, pectoral muscle, or axil-
lary lymph nodes, which are important for prognosis [3]. 
Morphological features with metastatic node, for example 
cortical thickening, loss of fatty hilum, heterogeneous en-
hancement, and round shape or a long to short axis ratio 
of less than 2, are considered suspicious. In prior studies, 
the presence of any axillary node with no fatty hilum seen 
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on MRI and with a high signal intensity on T2 sequences 
and marked gadolinium enhancement were found to be 
significantly correlated with metastatic lymph nodes [4,5]. 
As a result of this, we assessed the performance of 
breast MRI in evaluating axillary nodal staging in newly 
diagnosed breast cancer patients by using morphological 
characteristics of metastatic axillary lymph node. 
Material and methods
Study population
 We retrospectively reviewed preoperative breast MRIs of 
newly diagnosed breast cancer patients who underwent 
breast MRI at our academic institution from January 
2011 to December 2018. All patients underwent SLNB 
or ALND, and the pathological nodal stage was obtained. 
Timing from performing MRI to surgery was within two 
months.
Patients with carcinoma in situ (ductal or lobular; 
DCIS or LCIS), who previously had adjuvant chemother-
apy or whole breast radiation, and who had known breast 
cancer or prior axillary surgery were excluded from the 
study. This left us with a total of 131 patients. This study 
was approved by the Ethics Committee of the Faculty of 
Medicine, Chulalongkorn University.
Magnetic resonance imaging protocols
MRI was performed using a 1.5-Tesla system (Siemen Mag-
netom Espree, Siemens Medical Solutions, Erlangen, Ger-
many) with an eight-channel breast coil. 
The pre-contrast sequences include axial three-dimen-
sional high-resolution, fat-suppressed, T1-weighted, axi-
al, short-T1 inversion recovery (STIR), axial T2-weighted 
images turbo-spin echo (TSE), and coronal T1-weighted 
sequences. 
After the contrast injection, dynamic contrast-en-
hanced MRI (DCE-MR imaging) was performed with 
axial three-dimensional high-resolution T1-weighted, 
axial three-dimensional fat-suppressed T1-weighted with 
and without subtraction, DWI, ADC, sagittal T2-weighted 
turbo spin echo, and coronal T2-weighted sequences.
Magnetic resonance imaging evaluation
The axillary lymph nodes were divided into three levels by 
the pectoralis minor muscle as follows: level I was infero-
lateral to the pectoralis minor muscle, level II was behind 
the pectoralis minor muscles, and level III was superome-
dial to the pectoralis minor muscle [3] (Figures 1 and 2). 
All nodes were assessed by using axial T2-weight without 
Figure 1. Coronal magnetic resonance imaging (MRI) of the right axillary 
region, T2WI. The axilla is divided into three levels on the MRI in the coronal 
plane. Level I was inferolateral to the pectoralis minor muscle (yellow), level II 
was behind the pectoralis minor muscle (green), and level III was superome-
dial to the pectoralis minor muscle (blue) 
Figure 2. Axillary level I (A) and II (B) on magnetic resonance imaging axial T2WI. The axillary lymph node level I (arrow) is located lateral to the pectoralis 
minor muscle (green) while the axillary level II lymph node (arrowhead) is located behind the pectoralis minor muscle (green) 
A B
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fat suppression, post contrast T1-weight sequence, and 
coronal T2-weighted sequences.
All MRI data were separately evaluated by two radiolo-
gists who had more than 11 years’ experience in reading 
breast images. The observers were blinded to the patients’ 
information, radiological reports, and histopathological 
information to avoid bias. Consensus was made in cases 
of disagreement.
Morphology criteria of pathologic nodes were con-
sidered when there were two of three features of cortical 
thickening greater than 2 mm, short axis size greater than 
5 mm, and long to short axis ratio less than two. Signal in-
tensity on T2-weighted image and pattern of enhancement 
were also collected. N staging was determined based on the 
number of metastatic axillary lymph nodes as follows: N0 
– no regional lymph node metastasis, N1 – metastases in 
1-3 axillary lymph nodes, N2 – metastases in 4-9 axillary 
lymph nodes, and N3 – metastases in 10 or more axillary 
lymph nodes. 
Pathologic nodal staging
According to the American Joint Committee on Can-
cer (AJCC), pathological results were determined by 
the number of proven metastatic axillary lymph nodes 
based on the final pathologic results of the surgical 
specimens from SLNB or ALND, as follows: pN0 – his-
tologically no regional lymph node metastasis, pN1 – 
micrometastases or metastases in 1-3 axillary lymph 
nodes, pN2 – metastases in 4-9 axillary lymph nodes, 
and pN3 – metastases in 10 or more axillary lymph 
nodes. However, the axillary lymph node dissection was 
performed on level I and II axillary lymph nodes; there-
fore, our pathological surgical specimens were limited 
to just these levels. 
Statistical analysis
The mean ± SD was used for continuous data such as age, 
interval between preoperative breast MRI and surgical 
treatment, short axis, long axis, and long to short axis ra-
tio. Other demographic data and MRI characteristic were 
evaluated using percentages.
Sensitivity, specificity, positive predictive value, and 
negative predictive value were computed on 2 × 2 tables of 
true-positive, true-negative, false-positive, and false-nega-
tive values. Subgroup analyses of the different nodal stag-
ing were performed.
Figure 3. A 70-year-old female with right breast cancer. Axial magnet-
ic resonance imaging (MRI) of the right breast showed an enlarged level 
I axil lary lymph node without fatty hilum and thickened cortex (arrow). 
From the breast MRI, there was a hyper signal intensity on T2-weight-
ed image (A) with heterogeneous enhancement on contrast-enhanced 
T1-weighted image with fat suppression (B) and with subtraction (C), which 
looked suspiciously like a metastatic lymph node. This patient has pN3 stage 
from pathology
A
C
B
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The κ coefficient was analysed to assess how well the 
diagnoses of metastatic axillary lymph nodes based on 
MRI interpretation matched those based on pathologic 
evaluation at the pathological N staging. The strength of 
agreement beyond chance for various ranges of κ that were 
suggested by Landis and Koch [6] were used: κ < 0 – poor, 
κ = 0.00-0.20 – slight, κ = 0.21-0.40 – fair, κ = 0.41-0.60 – 
moderate, κ = 0.61-0.80 – substantial, and κ = 0.81-1.00 
– almost perfect.
Results
During the period from January 2011 to December 2018, 
131 women with breast cancer had preoperative breast 
MRI. The mean age of the patients was 51.33 years (range: 
28 to 84 years). All women underwent surgery as follows: 
52 (39.7%) patients had wide excision, axillary lymph 
node dissection; 73 (55.7%) patients had modified radi-
cal mastectomy; and six (4.6%) patients had sentinel node 
dissection. The mean interval between preoperative breast 
MRI and surgery was 36.13 days. The histopathological 
type of primary tumour was invasive ductal carcinoma 
metastasis (n = 118; 90.1%), invasive lobular carcinoma 
metastasis (n = 5; 3.8%), and other metastasis (n = 8; 
6.1%) (Table 1).
According to the pathologic results, 64 women 
(48.9%) had negative metastatic axillary lymph nodes 
(pN0), 39 women (29.8%) had metastases in 1-3 axillary 
lymph nodes (pN1), 18 women (13.7%) had metastases 
in 4-9 axillary lymph nodes (pN2), and 10 women (7.6%) 
had metastases in 10 or more axillary lymph nodes (pN3) 
(Table 1).
A total of 227 axillary lymph nodes were analysed 
from preoperative breast MRI, which were considered to 
be metastatic nodes. 193 (85%) nodes were level I (infe-
rolateral to the pectoralis minor muscle), 34 (15%) nodes 
were level II (behind the pectoralis minor muscles), and 
0 (0%) nodes were level III (superomedial to the pectoralis 
minor muscle). 
The long axis ranged from 0.5 to 3.3 cm (average 1.22 
± 0.50 cm), and the short axis ranged from 0.4 to 2.4 cm 
(average 0.79 ± 0.36 cm). The long to short axis ratio 
measurements of the lymph nodes ranged from 1.05 to 
3.75 (average 1.59 ± 0.35) (Table 2).
Table 1. Demographics of the study patients (n = 131)
Characteristic
(n = 131)
Mean ± SD
or n (%)
Median 
[min, max]
Age 51.33 ± 10.17 50 [28, 84]
Site
Right 72 (55%)
Left 59 (45%)
Surgery
Wide excision, axillary node 
dissection
52 (39.7%)
Modified radical mastectomy 73 (55.7%)
Sentinel node biopsy 6 (4.6%)
Histopathologic type
IDC 118 (90.1%)
ILC 5 (3.8%)
Other* 8 (6.1%)
Interval (day) 36.13 ± 36.18 25 [1, 203]
Pathological N staging
pN0 64 (48.9%)
pN1 39 (29.8%)
pN2 18 (13.7%)
pN3 10 (7.6%)
MRI results
N0 38 (29.0%)
N1 80 (61.1%)
N2 11 (8.4%)
N3 2 (1.5%)
IDC – invasive ducal carcinoma, ILC – invasive lobular carcinoma 
*Other subtypes of breast cancer
Pathological N staging: pN0 – no regional lymph node metastasis histologically, pN1 – micro-
metastases; or metastases in 1-3 axillary lymph nodes, pN2 – metastases in 4-9 axillary lymph 
nodes, pN3 – metastases in 10 or more axillary lymph nodes
MRI results (N staging): N0 – no regional lymph node metastasis, N1 – metastases in 1-3 axillary 
lymph nodes, N2 – metastases in 4-9 axillary lymph nodes, N3 – metastases in 10 or more 
axillary lymph nodes
Table 2. MRI characteristics of the axillary lymph nodes (n = 227)
N (%) or 
Mean ± SD
Median 
[min, max]
Site
Right 109 (48%)
Left 118 (52%)
Level
Level I 193 (85%)
Level II 34 (15%)
Level III 0 (0%)
Fatty hilum
Absence 179 (78.9%)
Presence 48 (21.1%)
Long axis 1.22 ± 0.50 1.1 [0.5, 3.3]
Short axis 0.79 ± 0.36 0.7 [0.4, 2.4]
L/S ratio 1.59 ± 0.35 1.55 [1.05, 3.75]
Hyper intense T2
Presence 227 (100%)
Enhancement
Homogeneous 92 (40.5%)
Heterogeneous 135 (59.5%)
 Breast MRI in the evaluation of axillary nodal metastasis
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Absent fatty hilum was observed in 179 metastatic ax-
illary lymph nodes (78.9%), and fatty hilum was seen in 
34 metastatic axillary lymph nodes (21.1%). All metastat-
ic nodes showed hyper signal intensity on T2-weighted 
image. 40.5% (n = 92) were homogeneous and 59.59% 
(n = 135) were heterogenous (Table 2). On the MRI, our 
true positive case that was considered to have metastatic 
axillary node did have a positive lymph node in the final 
pathology. 
In the subgroup analysis of N staging, our study also 
demonstrated that 65.65% (86 out of 131 patients) of the 
MRI results matched with the pathological results. Thirty- 
seven of 64 patients (57.81%) had N0 stage, 39 of 39 pa-
tients (100%) had N1 stage, eight of 18 patients (44.44%) 
had N2 stage, and two of 10 patients (2%) had N3 stage 
(Table 3). 
The sensitivity of breast MRI for detecting metastatic 
axillary lymph node was 98.5% (95% CI: 92-100%), and 
the negative predictive value was 96.4% (86.2-99.9%). 
The specificity of breast MRI for detecting metastatic axil-
lary lymph node was 57.8% (44.8-70.1%), and the positive 
predictive value was 71% (60.6-79.9%). 
The κ coefficient was analysed to assess the correlation 
of breast MRI with pathological axillary nodal staging. 
It was shown that there was a moderate agreement beyond 
chance (κ = 0.48, 95% CI: 0.386-0.539).
Discussion
Breast MRI is widely used for preoperative assessment 
for extension of breast cancer, axillary lymph node status, 
and screening of the contralateral breast in breast cancer 
patients [7]. The advantages of breast MRI over other im-
aging modalities are its accuracy for providing anatomical 
information of the breast and axilla. 
In our study, 227 MRIs that were considered as metas-
tasis axillary lymph nodes were collected from 131 wom-
en with breast cancer. The sensitivity, specificity, negative 
predictive value, and positive predictive value for detect-
ing axillary nodal metastasis in breast cancer were 98.5%, 
57.8%, 96.4%, and 71%, respectively. Our results support 
the findings from previous studies that assessed the diag-
nostic accuracy of breast MRI for detecting axillary nodal 
metastasis in breast cancer patients [8,9]. He et al. and 
Li et al. demonstrated high sensitivity (97% and 94.6%, 
respectively), and high negative predictive value (99.4% 
and 99.5%, respectively) of MRI to detect axillary lymph 
node metastasis in patients with breast cancer [8,9]. 
Despite the high sensitivity of breast MRI for deter-
mining metastatic nodes, overestimated or underestimat-
ed N staging can be found. In our data, there were over-
estimated and underestimated MRIs of N staging in 27 
out of 131 patients (20.61%) and in 17 out of 131 patients 
(12.98%), respectively.
However, breast MRI could detect early nodal metas-
tasis in breast cancer patients, especially N1 stage. Early 
detection of nodal metastasis is very helpful in designing 
the treatment plan for the patient. 
A limitation of our study is that it was a retrospective 
study. In our study, we could not compare level by level or 
node by node of the MRI positive nodes matched to the 
pathologic positive nodes. 
Conclusions
In conclusion, our study showed high sensitivity (98.5%) 
and high negative predictive value (96.4%) of breast 
MRI in detecting metastatic axillary lymph nodes, but 
its specificity was only fair (57.8%). 20.61% of the MRIs 
overestimated the N staging, and 12.98% of the MRIs un-
derestimated the N staging. Nevertheless, we found high 
performance of MRI in detecting the N1 stage, which is 
very helpful in designing the treatment plan for patients 
with early nodal metastases (pN1).
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Table 3. Correlation of breast MRI with pathological axillary nodal staging
MRI N staging Pathological N staging
pN0 pN1 pN2 pN3 Total
N0 37 0 1 0 38
N1 27 39 9 5 80
N2 0 0 8 3 11
N3 0 0 0 2 2
Total 64 39 18 10 131
Pathological N staging: pN0 – no regional lymph node metastasis histologically, pN1 – micrometastases; or metastases in 1-3 axillary lymph nodes, pN2 – metastases in 4-9 axillary lymph 
nodes, pN3 – metastases in 10 or more axillary lymph nodes
MRI results (N staging): N0 – no regional lymph node metastasis, N1 – metastases in 1-3 axillary lymph nodes, N2 – metastases in 4-9 axillary lymph nodes, N3 – metastases in 10 or more 
axillary lymph nodes
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